NIOSHTIC-2 Publications Search
Health hazard evaluation report: HETA-83-184-1416, Penn Emblem Company, Philadelphia, Pennsylvania.
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 83-184-1416, 1984 Feb; :1-5
Environmental and breathing zone samples were analyzed for toluene- diisocyanate (26471625) (TDI), cellosolve (110805), cellosolve- acetate (111159), xylenes, and methylene-chloride (75092) at Penn Emblem Company (SIC-3999), Philadelphia, Pennsylvania in April and August 1983. Evaluation was requested by Local 837 of the Teamsters Union expressing concern about exposure of press operators and ink blenders to solvents. TDI concentrations were below the detection limit. Concentrations of cellosolve ranged from 3.84 to 19.4 parts per million (ppm). Cellosolve-acetate concentrations were 2.05 to 15.2ppm. Mixed xylenes were found at 1.22 to 12.9ppm. Methylene- chloride concentrations were 8 to 483ppm; the NIOSH recommended standard is 75ppm. Other solvent concentrations were below OSHA standards. Ten of the 15 cellosolve and 6 of the 15 cellosolve- acetate samples were higher than the American Conference of Governmental Industrial Hygienists (ACGIH) standards of 5ppm. The author concludes that there were no excessive exposures to cellosolve, cellosolve-acetate or xylenes; however, using ACGIH or NIOSH criteria, cellosolve-acetate, cellosolve, and methylene- chloride exposure limits were exceeded. Recommendations include replacement of the solvent currently used with less toxic solvents, installation of adequate ventilation in the ink mixing room, and proper maintenance of the respirators.
NIOSH-Author; NIOSH-Health-Hazard-Evaluation; NIOSH-Technical-Assistance-Report; Hazards-Confirmed; Paint-industry; Region-3; Organic-solvents; Menstrual-disorders; Respiratory-irritants; Breathing-zone; HETA-83-184-1416; Author Keywords: cellosolve; cellosolve acetate; xylene; methylene chloride; chest pains; congestion; nose bleeds; headaches; menstrual problems
26471-62-5; 110-80-5; 111-15-9; 75-09-2
Field Studies; Hazard Evaluation and Technical Assistance
NTIS Accession No.
National Institute for Occupational Safety and Health
Page last reviewed: February 7, 2020
Content source: National Institute for Occupational Safety and Health Education and Information Division